Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
1.
Eur J Neurol ; 26(6): 865-871, 2019 06.
Article in English | MEDLINE | ID: mdl-30614590

ABSTRACT

BACKGROUND AND PURPOSE: Peripapillary retinal nerve fibre layer (pRNFL) thickness is a strong candidate as a biomarker of axonal degeneration in multiple sclerosis (MS). The aim was to determine a cut-off value of pRNFL thinning rates in relapsing-remitting MS (RRMS) to discriminate between stable and progressing patients. METHODS: In this 3-year prospective longitudinal study on 141 RRMS patients, annual pRNFL thinning rates (aLpRNFL) were determined by individual linear regression models. The best possible cut-off value discriminating clinically progressing (physical progression or cognitive decline) and stable patients was defined by receiver operating characteristic analysis. Cut-off values were validated using a multivariate logistic regression model. RESULTS: Average aLpRNFL in progressing patients (2.4 µm, SD 2.1) was significantly higher compared to stable patients (0.5 µm, SD 1.2, P < 0.001). At a predefined specificity of 90%, aLpRNFL >1.5 µm was able to distinguish between stable and progressing RRMS with a sensitivity of 76.1%. aLpRNFL >1.5 µm was associated with a 15-fold increased risk of clinically progressing MS (P < 0.001). CONCLUSIONS: A cut-off of aLpRNFL discriminating clinically progressing and stable RRMS was identified. After validation in independent cohorts, this cut-off could be used as a biomarker of axonal degeneration supporting disease monitoring in daily clinical routine.


Subject(s)
Multiple Sclerosis, Relapsing-Remitting/diagnostic imaging , Retina/diagnostic imaging , Adult , Biomarkers , Disease Progression , Female , Humans , Longitudinal Studies , Male , Middle Aged , Nerve Fibers , Prospective Studies , Sensitivity and Specificity , Tomography, Optical Coherence
2.
Neuropsychiatr ; 24(2): 67-87, 2010.
Article in German | MEDLINE | ID: mdl-20605003

ABSTRACT

The Austrian Alzheimer Society developed evidence-based guidelines based on a systematic literature search and criteria-guided assessment with subsequent transparent determination of grades of clinical recommendation. The authors evaluated currently available therapeutic approaches for the most common forms of dementia and focused on diagnosis and pharmacological intervention, taking into consideration the situation in Austria. The purpose of these guidelines is the rational and cost-effective use of diagnostic and therapeutic measures in dementing illnesses. Users are physicians and all other providers of care for patients with dementia in Austria.


Subject(s)
Dementia/diagnosis , Dementia/drug therapy , Evidence-Based Medicine , Nootropic Agents/therapeutic use , Aged , Aged, 80 and over , Amino Acids/adverse effects , Amino Acids/therapeutic use , Antipsychotic Agents/adverse effects , Antipsychotic Agents/therapeutic use , Cholinesterase Inhibitors/adverse effects , Cholinesterase Inhibitors/therapeutic use , Cognition Disorders/diagnosis , Cognition Disorders/drug therapy , Cross-Sectional Studies , Dementia/epidemiology , Dementia/etiology , Drug Therapy, Combination , Female , Ginkgo biloba , Humans , Incidence , Life Style , Long-Term Care , Male , Medication Adherence , Memantine/adverse effects , Memantine/therapeutic use , Middle Aged , Plant Extracts/adverse effects , Plant Extracts/therapeutic use , Population Dynamics , Psychotropic Drugs/adverse effects , Psychotropic Drugs/therapeutic use , Randomized Controlled Trials as Topic
5.
Lancet ; 352(9143): 1856-7, 1998 Dec 05.
Article in English | MEDLINE | ID: mdl-9851408
6.
Wien Klin Wochenschr ; 110(7): 243-52, 1998 Apr 10.
Article in German | MEDLINE | ID: mdl-9611340

ABSTRACT

Polyneuropathy developing in critically ill patients ("critical illness polyneuropathy"--CIP) is diagnosed with increasing frequency in intensive care units. CIP is an axonal polyneuropathy leading to difficulties in weaning from artificial ventilation and symmetrical flaccid tetraparesis. Pathogenetically CIP is considered to be part of the multiple organ dysfunction syndrome (MODS) in the course of sepsis or systemic inflammatory response syndrome (SIRS). The incidence of CIP in septic patients with MODS ranges from 50% to 70%. Electroneurography (ENG) and electromyography (EMG) are essential diagnostic procedures. The mortality in patients with CIP is higher than in patients without CIP. Depending on the severity of CIP, recovery of neurological function in survivors is usually relatively good.


Subject(s)
Critical Care , Multiple Organ Failure/diagnosis , Polyneuropathies/diagnosis , Systemic Inflammatory Response Syndrome/diagnosis , Diagnosis, Differential , Electromyography , Humans , Multiple Organ Failure/mortality , Multiple Organ Failure/therapy , Polyneuropathies/mortality , Polyneuropathies/therapy , Prognosis , Survival Rate , Systemic Inflammatory Response Syndrome/mortality , Systemic Inflammatory Response Syndrome/therapy
7.
J Neurol ; 244(9): 556-61, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9352452

ABSTRACT

Early determination of outcome after successful prehospital cardiopulmonary resuscitation (CPR) is a common problem with great ethical, economic, social, and legal consequences. We prospectively investigated 112 adult patients who had been resuscitated after out-of-hospital cardiac arrest (CA). The aim of our study was to determine whether coma rating by the mobile intensive care unit (MICU) is a useful tool for outcome prediction. For neurological assessment the Innsbruck Coma Scale (ICS) was used initially and after return of spontaneous circulation (ROSC) or 20-30 min after the start of CPR, before any sedating drugs were given. The duration of anoxia and CPR were determined with the automatically recorded emergency call protocol of the dispatch centre and the protocol of the MICU. For estimation of cerebral outcome at the time of discharge from hospital we used the Glasgow-Pittsburgh Cerebral Performance Categories (CPC). Restoration of spontaneous circulation was achieved in 42 patients (37%), and 15 (13%) were discharged from hospital. The first coma rating performed immediately at the time of arrival on scene had no significant prognostic value for prediction of neurological outcome (P = 0.204) and survival (P = 0.103). The second coma rating (performed after ROSC or 20-30 min after the start of CPR), however, demonstrated a significant correlation with neurological outcome (P = 0.0000) and survival (P = 0.0000), a correlation which was comparable to both duration of anoxia and duration of CPR. In patients with out-of-hospital cardiac arrest prognostic information could be obtained with the ICS as early as 20-30 min after the start of cardiopulmonary resuscitation.


Subject(s)
Ambulatory Care/methods , Cardiopulmonary Resuscitation , Coma/etiology , Heart Arrest/therapy , Hypoxia/etiology , Adolescent , Adult , Aged , Aged, 80 and over , Female , Heart Arrest/complications , Humans , Logistic Models , Male , Middle Aged , Probability , Prognosis , Prospective Studies , Treatment Outcome
10.
Eur Neurol ; 37(3): 135-45, 1997.
Article in English | MEDLINE | ID: mdl-9137924

ABSTRACT

Early determination of outcome after out-of-hospital cardiopulmonary resuscitation is a common problem with great ethical, economic, social and legal consequences. Although there has been a fulminant development of emergency medicine during the last three decades, severe cerebral damage sometimes cannot be avoided. For neurological outcome prediction after cardiac arrest clinical neurological signs, electrophysiological examinations, neuroimaging tests, and laboratory parameters in serum and cerebrospinal fluid are used today, nevertheless, there still remains a considerable degree of uncertainty. However, although prognostic criteria which enable the clinician to stop treatment cannot be given at the present time, useful applications of early prognostication after cardiac arrest range from counseling of families, triage decisions, and do-not-resuscitate decisions to future clinical investigations of brain resuscitative measures.


Subject(s)
Heart Arrest/complications , Heart Arrest/therapy , Hypoxia, Brain/therapy , Adult , Brain Ischemia/physiopathology , Electrophysiology/methods , Heart Arrest/physiopathology , Humans , Hypoxia, Brain/mortality , Hypoxia, Brain/physiopathology , Neurologic Examination , Predictive Value of Tests , Prognosis , Treatment Outcome
11.
Intensive Care Med ; 22(9): 849-55, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8905416

ABSTRACT

OBJECTIVE: To determine the incidence, severity and course of polyneuropathies in patients with sepsis or systemic inflammatory response syndrome combined with multiple organ failure. DESIGN: Prospective study. SETTING: Division of Intensive Care Medicine of the Department of Anesthesiology and Intensive Care and Intensive Care Unit of the Department of Neurology, University Hospital Innsbruck, Austria. PATIENTS: Twenty-two patients between 23 and 77 years old with sepsis or systemic inflammatory response syndrome combined with multiple organ failure fulfilling strict inclusion and exclusion criteria. INTERVENTIONS: Clinical neurologic examination and electro myography/nerve conduction velocity measurements during the stay on the Intensive Care Unit and 2-3 months later. MEASUREMENTS AND RESULTS: In 9 of the 22 patients signs of polyneuropathy were found at the initial clinical investigation and in 7 patients at the follow-up investigation. Electrophysiologic investigation revealed signs of polyneuropathy in 18 patients initially and in 11 patients 2-3 months later. CONCLUSION: In our patient population the frequency of the development of polyneuropathy was high (81.8%). Electrophysiologic investigation is superior to clinical neurologic examination in the detection of polyneuropathies.


Subject(s)
Multiple Organ Failure/complications , Neuromuscular Diseases/etiology , Sepsis/complications , Activities of Daily Living , Adult , Aged , Critical Illness , Electromyography , Female , Humans , Incidence , Male , Middle Aged , Neurologic Examination , Neuromuscular Diseases/diagnosis , Prospective Studies , Severity of Illness Index , Survival Analysis
14.
Am J Med Genet ; 67(1): 31-9, 1996 Feb 16.
Article in English | MEDLINE | ID: mdl-8678111

ABSTRACT

Hereditary factors play a major role in the etiology of idiopathic generalized epilepsies (IGEs). A trait locus (EBN1) for a rare subtype of IGEs, the benign neonatal familial convulsions, and a susceptibility gene (EEGV1) for the common human low-voltage electroencephalogram have been mapped close together with D20S19 to the chromosomal region 20q13.2. Both loci are potential candidates for the susceptibility to IGE spectra with age-related onset beyond the neonatal period. The present study tested the hypothesis that a putative susceptibility locus linked to D20S19 predisposes to spectra of IGEs with age-related onset from childhood to adolescence. Linkage analyses were conducted in 60 families ascertained through IGE patients with juvenile myoclonic epilepsy, juvenile absence epilepsy or childhood absence epilepsy. Our results provide evidence against linkage of a putative susceptibility gene for four hierarchically broadened IGE spectra with D20S19 assuming tentative single-locus genetic models. The extent of an "exclusion region" (lod scores below-2) varied from 0.5 cM up to 22 cM on either side of D20S19 depending on the trait assumed. These results are contrary to the expectation that a susceptibility gene in vicinity to D20S19 confers a common major gene effect to the expression of IGE spectra with age-related onset from childhood to adolescence.


Subject(s)
Chromosomes, Human, Pair 20 , Epilepsies, Myoclonic/genetics , Epilepsy, Absence/genetics , Genetic Linkage , Chromosome Mapping , Female , Genetic Markers , Humans , Male , Pedigree
15.
Ann Neurol ; 38(2): 210-7, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7654068

ABSTRACT

Linkage studies of families ascertained through patients with juvenile myoclonic epilepsy (JME) suggest that an HLA-linked susceptibility gene on chromosome 6, designated "EJM1," predisposes to a group of idiopathic generalized epilepsies (IGEs) comprising JME, juvenile absence epilepsy (JAE), childhood absence epilepsies (CAE), and epilepsies with generalized tonic-clonic seizures (GTCS). To explore the EJM1-related phenotypic spectrum, we conducted linkage studies with HLA-DQ alpha restriction fragment length polymorphisms in 44 families ascertained through patients with CAE or JAE. Our results for the entire group of families provide evidence against a major susceptibility locus for idiopathic absence epilepsies and broader spectra of IGEs in the HLA region. Lod scores less than -2 were obtained for a region from 10 cM up to 23 cM on either side of the HLA-DQ alpha locus, depending on the assumed trait model. Suggestive evidence for linkage was found only for a subgroup of families with JME patients assuming an autosomal dominant mode of inheritance with 70% penetrance. A maximum lod score was obtained when family members with JME, JAE, CAE, and idiopathic GTCS were included into the affection status. Our results demonstrate that (1) the genetic susceptibility to idiopathic absence epilepsies and broader spectra of IGEs is heterogeneous, (2) the gene effect of EJM1 depends on the familial genetic background, and (3) EJM1 confers genetic susceptibility to idiopathic absence epilepsies and broader spectra of IGEs in the presence of family members with JME.


Subject(s)
Epilepsy/genetics , Disease Susceptibility , Female , Genetic Linkage , HLA-DQ Antigens/genetics , HLA-DQ alpha-Chains , Humans , Male , Pedigree , Phenotype
16.
Infection ; 23(4): 240-2, 1995.
Article in English | MEDLINE | ID: mdl-8522384

ABSTRACT

Aspergillosis of the central nervous system (CNS) is an uncommon infection, mainly occurring in immunocompromised patients. Beside cerebral involvement spinal cord lesions are extremely rare. To our knowledge, aspergillosis initially presenting with acute paraplegia due to mycotic thrombosis of the anterior spinal artery in a formerly healthy patient has, so far, not been reported. Neither a primary focus nor an underlying disease had been detected.


Subject(s)
Aspergillosis/complications , Spinal Diseases/microbiology , Spine/blood supply , Thrombosis/microbiology , Acute Disease , Adult , Aspergillosis/pathology , Aspergillus/isolation & purification , Brain/microbiology , Cervical Vertebrae , Humans , Magnetic Resonance Imaging , Male , Paraplegia/microbiology , Paraplegia/pathology , Spinal Diseases/pathology , Syndrome , Thrombosis/pathology
17.
Stroke ; 26(4): 543-9, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7709394

ABSTRACT

BACKGROUND AND PURPOSE: Although there are various methods of determining neurological prognosis after cardiopulmonary resuscitation, the final outcome of patients often remains unclear for quite a long time. METHODS: We investigated 30 consecutively admitted patients who had been successfully resuscitated by the team of the local mobile intensive care unit after cardiac arrest. Determinations of the period of anoxia and of the cardiopulmonary resuscitation time, clinical investigation, echocardiography, electroencephalography, evoked potentials, magnetic resonance imaging, and magnetic resonance spectroscopy were performed. RESULTS: Demonstration of brain lactate in proton magnetic resonance spectroscopy (P < .01) and absent N20 waves in short-latency somatosensory evoked potentials (P < .01) proved to be significant in terms of a poor prognosis. Correlations between both duration of anoxia and cardiopulmonary resuscitation time and neurological outcome could be shown as well (both P < .05). CONCLUSIONS: Proton magnetic resonance spectroscopy and short-latency evoked potentials are of great benefit in the prognostic evaluation after cardiopulmonary resuscitation.


Subject(s)
Brain/pathology , Cardiopulmonary Resuscitation , Heart Arrest/therapy , Adolescent , Adult , Aged , Aged, 80 and over , Aspartic Acid/analogs & derivatives , Aspartic Acid/analysis , Brain/metabolism , Electrophysiology , Female , Heart Arrest/pathology , Humans , Lactates/analysis , Lactic Acid , Magnetic Resonance Imaging , Magnetic Resonance Spectroscopy , Male , Middle Aged , Neurologic Examination , Prognosis
19.
J Neurol Sci ; 123(1-2): 2-5, 1994 May.
Article in English | MEDLINE | ID: mdl-8064315

ABSTRACT

We report a single-case study of a patient suffering from Marchiafava-Bignami disease (MBD), a rarely intra vitam diagnosed syndrome with focal demyelination in the corpus callosum, which is usually found in patients with chronic alcohol abuse. Our study explored a variety of motor, sensory and visual functions. Striking features were left apraxia caused by two lesions in the rostral area, and left hemidyslexia related to a large splenial lesion demonstrated by MRI. As symptoms of disconnection may remain undetected clinically, MRI is a most useful tool for the diagnosis of MBD.


Subject(s)
Brain/pathology , Demyelinating Diseases/pathology , Demyelinating Diseases/physiopathology , Magnetic Resonance Imaging , Adult , Alcoholism/pathology , Alcoholism/physiopathology , Atrophy , Cerebellum/pathology , Corpus Callosum/pathology , Demyelinating Diseases/psychology , Electroencephalography , Humans , Male , Neuropsychological Tests , Reading
20.
Wien Klin Wochenschr ; 106(5): 128-35, 1994.
Article in German | MEDLINE | ID: mdl-8171868

ABSTRACT

Neurological manifestations of diabetes mellitus comprise structural changes in both central and peripheral nervous system, as well as functional cerebral disturbances. Macro- and microangiopathy are responsible for the development of cerebrovascular diseases; microangiopathic and metabolic disturbances are considered in the discussion to be responsible for the development of the various forms of diabetic polyneuropathy. Acute metabolic episodes with progressive impairment of consciousness have to be differentiated from structural neurological disorders. As a further point of interest the association between diabetes mellitus and special neurological diseases is mentioned.


Subject(s)
Diabetic Neuropathies/diagnosis , Brain Diseases, Metabolic/diagnosis , Brain Diseases, Metabolic/physiopathology , Central Nervous System/physiopathology , Diabetic Angiopathies/diagnosis , Diabetic Angiopathies/physiopathology , Diabetic Neuropathies/physiopathology , Humans , Neurologic Examination , Peripheral Nervous System/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...